FdaApplication
BLA 761279
Identifiers
- fda_app_no: BLA761279
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 2023-10-26 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMVOH | MIRIKIZUMAB-MRKZ | 300MG/15ML (20MG/ML) | VIAL;SINGLE-USE |
| OMVOH | MIRIKIZUMAB-MRKZ | 100MG/ML | Injection |
| OMVOH | — | 100MG/ML | Injection |
| OMVOH | — | 200MG/2ML (100MG/ML) | Injection |
| OMVOH | — | 200MG/2ML (100MG/ML) | Injection |
5 products